Grant: Discovery Grants Program - Individual
University of Manitoba
$40,000.00
Allosteric citrate synthase
EF 2008-09
Résumé
The enzyme citrate synthase plays a central role in the production of metabolic energy in almost all organisms. In most organisms, including humans, the enzyme catalyzes its reaction as quickly as possible, with no braking mechanism as long as the raw materials are available. In one large class of bacteria, the Gram-negative bacteria, the situation is more complex: under certain conditions, it can be inhibited (shut down completely) by a biological reducing agent, NADH. To make this regulation possible, Gram-negative citrate synthase has evolved to a larger enzyme which can exist in either an active form, or in a second form which interacts with NADH and is inactive. We have been able to use the method of X-ray crystallography to determine the complete structure of Gram-negative citrate synthase in the NADH-binding or inactive form. In the present research, we wish to use molecular biology methods to force this enzyme into the active form, and determine that structure. Our second aim is to exploit the fact that Gra-negative citrate synthase can be turned off, while the human enzyme cannot, to design new antimicrobial drugs. Some of the most dangerous bacterial pathogens (like E. coli, involved in some kinds of food and water poisoning, and Pseudomonas aeruginosa, involved in lung infections in cystic fibrosis) are Gram-negatives. We are using high-throughput screening of chemical libraries to identify novel compounds that can inhibit Gram-negative citrate synthase, as NADH does, and then refine these discoveries in the hope of producing antimicrobials that can turn off Gram-negative bacterial growth in the case of infections, while having no effect on the human enzyme.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
6862-2008
Name nom
Duckworth, Harry
Department département
Chemistry
Organization id
19
Institution établissement
University of Manitoba
Province en
Manitoba
Province fr
Manitoba
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2008
Award amount
40000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5404
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Enzymes
Research subject fr
Enzymes
Partie
1
Nb partie
5
Application title
Allosteric citrate synthase
Keyword
NA
Application summary
The enzyme citrate synthase plays a central role in the production of metabolic energy in almost all organisms. In most organisms, including humans, the enzyme catalyzes its reaction as quickly as possible, with no braking mechanism as long as the raw materials are available. In one large class of bacteria, the Gram-negative bacteria, the situation is more complex: under certain conditions, it can be inhibited (shut down completely) by a biological reducing agent, NADH. To make this regulation possible, Gram-negative citrate synthase has evolved to a larger enzyme which can exist in either an active form, or in a second form which interacts with NADH and is inactive. We have been able to use the method of X-ray crystallography to determine the complete structure of Gram-negative citrate synthase in the NADH-binding or inactive form. In the present research, we wish to use molecular biology methods to force this enzyme into the active form, and determine that structure. Our second aim is to exploit the fact that Gra-negative citrate synthase can be turned off, while the human enzyme cannot, to design new antimicrobial drugs. Some of the most dangerous bacterial pathogens (like E. coli, involved in some kinds of food and water poisoning, and Pseudomonas aeruginosa, involved in lung infections in cystic fibrosis) are Gram-negatives. We are using high-throughput screening of chemical libraries to identify novel compounds that can inhibit Gram-negative citrate synthase, as NADH does, and then refine these discoveries in the hope of producing antimicrobials that can turn off Gram-negative bacterial growth in the case of infections, while having no effect on the human enzyme.